Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
01/2010
01/19/2010CA2472115C Colorant compounds
01/19/2010CA2402751C Decahydro-isoquinolines
01/19/2010CA2368097C Amide derivatives of 3,4-dihydroquinazolinone compounds useful as cytokine inhibitors
01/19/2010CA2239904C Inhibitors of interleukin-1.beta. converting enzyme
01/14/2010WO2010006191A1 4-phenoxymethylpiperidines as modulators of gpr119 activity
01/14/2010WO2010005783A1 Pyrrolidinyl and piperidinyl compounds useful as nhe-1 inhibitors
01/14/2010WO2010004782A1 Prolineamide derivative, salt thereof with acid, organic catalyst consisting of the same and method of producing β-hydroxycarbonyl compound using the organic catalyst
01/14/2010WO2010004215A2 Substituted 1-benzyl-cinnolin-4(1h)-one derivatives, preparation thereof, and therapeutic use thereof
01/14/2010WO2010003624A2 Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof
01/14/2010WO2009132453A8 Cyclylamine derivatives as calcium channel blockers
01/14/2010US20100010241 Cosmetics
01/14/2010US20100010042 Arylvinylazacycloalkane compounds and methods of preparation and use thereof
01/14/2010US20100010023 Quinazoline derivatives and pharmaceutical compositions containing them
01/14/2010US20100010007 Piperidine derivatives as modulators of chemokine receptor ccr5
01/14/2010US20100010004 Inhibitors of histone deacetylase
01/14/2010US20100010003 Pyrimidine Derivatives And Their Use As Pesticides
01/14/2010US20100009988 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
01/14/2010US20100009973 Integrase Inhibitors 3
01/14/2010US20100009972 Pyridyl Non-Aromatic Nitrogen-Containing Heterocyclic-1-Carboxylate Compound
01/14/2010US20100009971 Pyridyl Non-Aromatic Nitrogen-Containing Heterocyclic-1-Carboxylate Compound
01/14/2010CA2730511A1 4-phenoxymethylpiperidines as modulators of gpr119 activity
01/14/2010CA2730280A1 5-quinolinone and imidazopyridine compounds and use thereof
01/14/2010CA2730116A1 Pyrrolidinyl and piperidinyl compounds useful as nhe-1 inhibitors
01/14/2010CA2729896A1 Substituted 1-benzyl-cinnolin-4(1h)-one derivatives, preparation thereof, and therapeutic use thereof
01/13/2010EP2143714A1 Tetrahydroisoquinoline compound
01/13/2010EP2143713A1 Novel pyrrolinone derivative and medicinal composition containing the same
01/13/2010EP2142538A1 Derivatives and analogs of chroman as functionally selective alpha2c adrenoreceptor agonists
01/13/2010EP2142528A1 1-(1-benzylpiperidin-4-yl)benzimidaz0le -5-carboxylic acid derivatives for the treatment of diabetes mellitus
01/13/2010EP2142524A1 Novel 5-cyano-prostacyclin derivatives and their use as agents for the treatment of influenza a viral infection
01/13/2010EP2142515A1 Novel inhibitors
01/13/2010EP2142514A1 Thiourea derivatives as glutaminyl cyclase inhibitors
01/13/2010EP2142513A1 Nitrovinyl-diamine derivatives as glutaminyl cyclase inhibitors
01/13/2010EP2142509A2 Quinolones and azaquinolones that inhibit prolyl hydroxylase
01/13/2010EP2142503A2 Process for the manufacture for non-steroidal anti-inflammatory agents and intermediates thereof
01/13/2010EP1451160B1 Pyrazole-amides for use in the treatment of pain
01/13/2010EP1144388B1 Acyl derivatives which treat vla-4 related disorders
01/13/2010CN101627032A Process for the preparation of (r) -5- (2-aminoethyl) -1- (6, 8-difluorochroman-3-yl) -1, 3-dihydroimidazole-2-thione
01/13/2010CN100579976C P38 inhibitors and methods of use thereof
01/12/2010US7645891 E.g., 4-(2-methyl-3-oxo-hept-6-en-2-yl)-2,2-dimethyl-[1,3]-dioxane chemical intermediate; chemical/metabolic stabilization of microtubuli; antitumor, -carcinogenic agents; malignant melanoma, acute lymphocytic/myelocytic leukemia; angiogenesis inhibitors; antiinflammatory/-arthritic agents; psoriasis
01/12/2010US7645878 Reacting an aniline derivative with an acylchloride to form an intermeidate, cyclizing the intermediate, replacing hydroxy group with a leaving group (chloride), racting the product with an amino-heterocyclic compound
01/12/2010US7645789 Modulators of ATP-Binding Cassette transporters; Cystic Fibrosis Transmembrane Conductance Regulator; N-(5-hydroxy-2,4-ditert-butyl-phenyl)-4-oxo-1H-quinoline-3-carboxamide
01/12/2010US7645784 Benzimidazole derivatives
01/12/2010US7645774 Sulfonamide-containing benzene derivatives; cancer and inflammatory, immunomodulatory or respiratory diseases; allergy, seasonal allergic rhinitis, reversible airway obstruction, adult respiratory distress syndrome, asthma, or bronchitis
01/12/2010US7645770 Phenylalanine enamide derivatives
01/12/2010US7645761 Indoline derivatives
01/12/2010US7645759 (4-(S)-amino-5-(4-{4-[2,4-dichloro-3-(2,4-dimethyl-quinolin8yloxy-methyl) benzenesulfonylamino] tetrahydropyran-4carbonyl}-piperazin-1-yl)-5-oxo-pentyl] trimethyl-ammonium chloride, dihydrochloride; asthma or chronic bronchitis
01/12/2010US7645757 Derivatives of heteroaryl-alkylcarbamates, methods for their preparation and use thereof as fatty acid amido hydrolase enzyme inhibitors
01/12/2010CA2560489C Pyranone compounds useful to treat retroviral infections
01/12/2010CA2511242C Inhibitors of human tumor-expressed ccxckr2
01/12/2010CA2411418C Hydroxyformamidine derivatives and medicines containing the same
01/12/2010CA2407463C N-substituted peptidyl nitriles as cysteine cathepsin inhibitors
01/12/2010CA2399062C Stereoselective synthesis of nucleoside analogues
01/12/2010CA2391643C Gamma-hydroxy-2-(fluoroalkylaminocarbonyl)-1-piperazinepentanamides as hiv protease inhibitors
01/12/2010CA2384018C Muscarinic antagonists
01/12/2010CA2306428C 3-oxo-2(h)-1,2,4 - triazine derivatives as ligands of 5ht1a receptors
01/07/2010WO2010003048A1 Benzimidazoles and related analogs as sirtuin modulators
01/07/2010WO2010003025A1 Bicyclic heterocycles as mek kinase inhibitors
01/07/2010WO2010002483A1 Optionally condensed dihydro pyridine, dihydropyrimidine and dihydro pyrane derivatives acting as late sodium channel blockers
01/07/2010WO2010002075A1 Methods for preparing amide derivatives
01/07/2010WO2010001946A1 Triazole derivative or salt thereof
01/07/2010WO2010000773A1 5-heterocyclylalkyl-3-hydroxy-2-phenylcyclopent-2-enones as herbicides
01/07/2010WO2010000668A1 A crystalline form of posaconazole
01/07/2010WO2009108525A3 Hexahydrocyclopentyl[f]indazole carboxamides and derivatives thereof as selective glucocorticoid receptor modulators
01/07/2010US20100004456 Oxepin derivative
01/07/2010US20100004444 Novel Triazolo pyrimidine compounds
01/07/2010US20100004438 Diarylether derivatives as antitumor agents
01/07/2010US20100004290 Insecticidal n-substituted (heteroaryl)cycloalkyl sulfoximines
01/07/2010US20100004233 Novel coumarin derivative having antitumor activity
01/07/2010US20100004208 Substituted benzofurans, benzothiophenes, benzoselenophenes and indoles and their use as tubulin polymerisation inhibitors
01/07/2010US20100003216 HCV NS-3 Serine Protease Inhibitors
01/07/2010CA2729745A1 Oxindole compounds
01/07/2010CA2729724A1 5-heterocyclylalkyl-3-hydroxy-2-phenylcyclopent-2-enones as herbicides
01/07/2010CA2729408A1 Triazole derivative or salt thereof
01/07/2010CA2729128A1 Benzimidazoles and related analogs as sirtuin modulators
01/07/2010CA2728170A1 A crystalline form of posaconazole
01/07/2010CA2727250A1 Bicyclic heterocycles as mek kinase inhibitors
01/07/2010CA2726999A1 New drugs for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases
01/06/2010EP2141160A1 Ground crystal of olmesartan medoxomil
01/06/2010EP2141159A1 A Crystalline form of posaconazole
01/06/2010EP2140868A1 Use of a cholinesterase inhibitor for the treatment of dementia and cognitive impairments associated with or caused by chemotherapy
01/06/2010EP2140864A2 Use of GAL3 receptor antagonists for the treatment of depression and / or anxiety and compounds useful in such methods
01/06/2010EP2140862A2 Use of GAL 3 receptor antagonists for the treatment of depression and /or anxiety and compounds useful in such methods
01/06/2010EP2139885A1 Co-crystals of propiconazole
01/06/2010EP2139857A1 Sub-type selective azabicycloalkane derivatives
01/06/2010EP1735278B1 Histamine h3 receptor agents, preparation and therapeutic uses
01/06/2010EP1562911B1 Compositions useful as inhibitors of jak and other protein kinases
01/06/2010EP1489078B1 Benzofuran derivative
01/06/2010EP0934281B1 1-phenyl-benzimidazole compounds and their use as baga- a? receptor modulators
01/06/2010CN101622248A N3-heteroaryl substituted triazoles and N5-heteroaryl substituted triazoles useful as AXL inhibitors
01/06/2010CN101619059A Method for preparing osemozotan hydrochloride
01/06/2010CN101619057A N-substituted piperidine derivatives as serotonin receptor agents
01/06/2010CN100577658C 喹唑啉衍生物 Quinazoline derivatives
01/06/2010CN100577643C Substituted 1,4-di-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists
01/06/2010CN100577163C Compounds effecting glucokinase
01/05/2010US7642378 Lipid lowering biphenylcarboxamides
01/05/2010US7642359 Pyrazolyl-substituted heterocycles and their use as phytosanitary products
01/05/2010US7642354 Polycyclic pyrazines as potassium ion channel modulators
01/05/2010US7642351 2,4-Pyrimidinediamine compounds and their uses
01/05/2010US7642277 Non-nucleoside reverse transcriptase inhibitors
01/05/2010US7642276 N-[4-methyl-3-(3-piperidin-4-yl-1,2-benzisoxazol-6-yl)phenyl]-2-pyrrolidin-1-ylisonicotinamide; rheumatoid arthritis